Novo Nordisk shares fall after ZEUS trial disappointment highlights 94% sales reliance

Novo Nordisk A/S finished the week with a smaller rally than the rest of the Danish market. B shares closed Friday at DKK 326.90, dropping 1.54% on the day but still up 2.8% for the week. The OMX Copenhagen 25 gained 5.5% in the same period, so the stock lagged the benchmark by about 2.6 percentage points. Novo’s Friday volume hit 2.58 million shares, or 45% of its 65-day average, according to MarketWatch. For the week, turnover was 19.23 million shares, down from 25.66 million a week earlier. Investing.com reported the OMXC25 at 1,899.12 on Friday, up from 1,800.88 the previous week.